What is Danoprevir used for?

Danoprevir is being researched as a treatment for Hepatitis C virus infections, including chronic cases.

Is Danoprevir approved for use yet?

No, Danoprevir is currently in Phase 3 clinical trials and has not received FDA approval.

What type of drug is Danoprevir?

Danoprevir is classified as a small molecule drug.

Can Danoprevir treat chronic Hepatitis C?

Yes, one of the primary uses being studied for Danoprevir is chronic hepatitis C virus infection.

What is the mechanism of action for Danoprevir?

It acts as an NS3/NS4A inhibitor to stop the Hepatitis C virus protease.

danoprevir | CAS 850876-88-9 | ZVTDLPBHTSMEJZ

Loading compound...

Hepatitis C virus serine protease inhibitor

Danoprevir is a small molecule drug being studied for its ability to treat Hepatitis C. It works by targeting and inhibiting the NS3/NS4A serine protease, which is an enzyme the Hepatitis C virus needs to replicate.

How it worksDanoprevir stops the Hepatitis C virus from multiplying by blocking a specific enzyme called NS3/NS4A protease.

Used for

Chronic hepatitis C virus infectionHepatitis C virus infection

Conditions

Hepatitis C

Class

Serine protease inhibitorHepatitis C virus serine protease inhibitorHepatic

How to take

Danoprevir is currently in Phase 3 clinical trials and is not yet an approved medication for general use.

Talk to your doctor

Questions to ask

·Is Danoprevir a candidate for my Hepatitis C treatment?
·What are the potential side effects of Danoprevir in clinical trials?
·How does Danoprevir interact with my current medications?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)